Angiogenesis in epithelian ovarian cancer
- PMID: 12456770
- PMCID: PMC1187269
- DOI: 10.1136/mp.55.6.348
Angiogenesis in epithelian ovarian cancer
Abstract
Angiogenesis, the development of new blood vessels from the existing vasculature, is an essential component of solid tumour growth and metastasis. Several angiogenic factors are expressed by many tumours, suggesting that tumours promote their own vascularisation by activating the host endothelium. This review will discuss various angiogenic stimulators and inhibitors in epithelian ovarian cancer (EOC), including vascular endothelial growth factor and platelet derived endothelial cell growth factor/thymidine phosphorylase. The analysis of tumour vascularisation by microvessel density will also be discussed and the relevance of these markers of angiogenesis in the prognosis of EOC will be assessed.
Figures

Similar articles
-
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.Oncol Rep. 2003 Jan-Feb;10(1):89-95. Oncol Rep. 2003. PMID: 12469150
-
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.Cancer Res. 2003 Jun 15;63(12):3403-12. Cancer Res. 2003. PMID: 12810677
-
Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.Int J Oncol. 2003 May;22(5):961-7. Int J Oncol. 2003. PMID: 12684660
-
Prognostic role of angiogenesis in colorectal cancer.Anticancer Res. 2001 Nov-Dec;21(6B):4349-53. Anticancer Res. 2001. PMID: 11908690 Review.
-
[Neoplasms and angiogenesis].Pol Merkur Lekarski. 2002 Sep;13(75):225-8. Pol Merkur Lekarski. 2002. PMID: 12474576 Review. Polish.
Cited by
-
Phase II testing of sunitinib: the National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182-185.Curr Oncol. 2007 Aug;14(4):154-61. doi: 10.3747/co.2007.132. Curr Oncol. 2007. PMID: 17710208 Free PMC article.
-
Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis.J Ovarian Res. 2022 Jul 26;15(1):87. doi: 10.1186/s13048-022-01023-y. J Ovarian Res. 2022. PMID: 35883110 Free PMC article.
-
Tumor and reproductive traits are linked by RNA metabolism genes in the mouse ovary: a transcriptome-phenotype association analysis.BMC Genomics. 2010 Dec 22;11 Suppl 5(Suppl 5):S1. doi: 10.1186/1471-2164-11-S5-S1. BMC Genomics. 2010. PMID: 21210965 Free PMC article.
-
Exenatide modulates tumor-endothelial cell interactions in human ovarian cancer cells.Endocr Connect. 2017 Nov;6(8):856-865. doi: 10.1530/EC-17-0294. Epub 2017 Oct 17. Endocr Connect. 2017. PMID: 29042458 Free PMC article.
-
Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.Clin Transl Med. 2021 May;11(5):e425. doi: 10.1002/ctm2.425. Clin Transl Med. 2021. PMID: 34047469 Free PMC article.
References
-
- Czernobilsky B. Common epithelial tumors of the ovary. Blaustein’s pathology of the female genital tract, RJ Kurman, ed. New York: Springer-Verlag, 1987.
-
- Kristensen GB, Trope C. Epithelian ovarian carcinoma. Lancet 1997;349:113–17. - PubMed
-
- Land A. Ovulation, ovulation induction and ovarian carcinoma. Ballieres Clin Obstet Gynaecol 1993;7:455. - PubMed
-
- Russell P, Bannatyne P. Surgical pathology of the ovaries, Appendix B. Edinburgh: Churchill Livingstone, 1989.
-
- Serove S, Sculy R, Sobin L. The molecular pathogenesis of ovarian cancer. In: International histological classification of tumours. No. 9: Histological typing of ovarian tumours. Geneva: World Health Organisation, 1973:46–50.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical